PubMed:12626384 / 234-411
Annnotations
sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| TextSentencer_T3 | 0-177 | Sentence | denotes | Two recombinant protein therapeutics, Fabrazyme (agalsidase beta) and Replagal (agalsidase alfa), have been approved in Europe as enzyme replacement therapies for Fabry disease. |
| T3 | 0-177 | Sentence | denotes | Two recombinant protein therapeutics, Fabrazyme (agalsidase beta) and Replagal (agalsidase alfa), have been approved in Europe as enzyme replacement therapies for Fabry disease. |
GlycoBiology-FMA
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| _T7 | 16-23 | FMAID:67257 | denotes | protein |
| _T8 | 16-23 | FMAID:165447 | denotes | protein |
uniprot-human
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T2 | 49-59 | http://www.uniprot.org/uniprot/P06280 | denotes | agalsidase |
| T3 | 80-90 | http://www.uniprot.org/uniprot/P06280 | denotes | agalsidase |
GlycoBiology-NCBITAXON
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 60-64 | http://purl.bioontology.org/ontology/NCBITAXON/3554 | denotes | beta |
| T2 | 60-64 | http://purl.bioontology.org/ontology/NCBITAXON/158455 | denotes | beta |
EDAM-topics
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T6 | 16-23 | http://edamontology.org/topic_0078 | denotes | protein |
| T7 | 169-176 | http://edamontology.org/topic_0634 | denotes | disease |
EDAM-DFO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T2 | 16-23 | http://edamontology.org/format_1208 | denotes | protein |
| T3 | 16-23 | http://edamontology.org/data_1467 | denotes | protein |
mondo_disease
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T4 | 163-176 | Disease | denotes | Fabry disease | http://purl.obolibrary.org/obo/MONDO_0010526 |